Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Analgesic potential for PAR4 agonists

Sep. 20, 2006

Lyrica indications broadened in E.U. to include central neuropathic pain

Sep. 19, 2006

Ginkgo biloba extract effective against postsurgical hypersensitivity

Sep. 19, 2006

Amgen presents novel TRPV1 antagonists with antinociceptive efficacy

Sep. 19, 2006

NovaDel Pharma adds oral spray drug development candidates to pipeline

Sep. 19, 2006

Novel agents for anxiety, schizophrenia, etc., found in recent patents

Sep. 18, 2006

Evotec discontinues EVT-301 development following liver function findings

Sep. 18, 2006

Two-year data show treatment effect of Campath in MS

Sep. 18, 2006

NeuroMedix advances preclinical testing of Alzheimer's candidate Minozac

Sep. 18, 2006

Compounds with potential use in neurological disorders disclosed

Sep. 15, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...